Funded Biotechnology Startups in South Korea
Among the 11 most recent biotechnology rounds in South Korea, the largest disclosed amount is LegoChem Biosciences’ $214M on 2026-06-26.
Among the 11 most recent biotechnology rounds in South Korea, the largest disclosed amount is LegoChem Biosciences’ $214M on 2026-06-26. That figure dwarfs the next-largest disclosed rounds in this slice—April Bio’s $124M (2026-06-25) and LabGenomics’ $13M (2026-06-08)—while several other entries cluster far below $25M, including ADEL at $2M (2026-06-11) and Jeju Salt, which is undisclosed (2026-04-22).
The disclosed rounds shown are concentrated in a tight late-June window: most entries fall between 2026-06-08 and 2026-06-26, with additional points in early-to-mid April (2026-04-07 through 2026-04-23). City concentration is also noticeable: Seoul-based listings dominate (ADEL 2026-06-11 $2M; Cureverse 2026-05-21 $990K; Spark Biopharma 2026-05-11 $21M; Shaperon 2026-04-09 $6M; ROKIT Healthcare 2026-04-13 undisclosed; plus multiple entries labeled “Seoul-t'ukpyolsi” and two Seoul addresses overall), while Daejeon (LegoChem Biosciences, 2026-06-26 $214M) and Jeju (Jeju Salt, 2026-04-22 undisclosed) appear as smaller geographic pockets. Stage disclosure is mostly “Series Unknown” (9 of 11 rows), with one Seed (Jeju Salt, 2026-04-22) and one additional row where amount is disclosed but series remains “Series Unknown.”
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed biotech round in this South Korea slice, and how does it compare to the rest of the disclosed amounts?
LegoChem Biosciences’ $214M on 2026-06-26 is the only disclosed round above $100M here. The next-largest disclosed amount is April Bio’s $124M on 2026-06-25, while several other disclosed rounds sit much lower, such as LabGenomics at $13M (2026-06-08) and ADEL at $2M (2026-06-11).
Are there date clusters in these 11 most recent rounds?
Yes. 2026-06-25 through 2026-06-26 alone includes April Bio ($124M on 2026-06-25) and LegoChem Biosciences ($214M on 2026-06-26). More broadly, most entries fall between 2026-06-08 (LabGenomics $13M) and 2026-06-26 (LegoChem Biosciences), with remaining rows concentrated in early April (2026-04-07 to 2026-04-23).
Which cities show up most often among the listed companies?
Seoul (including “Seoul-t'ukpyolsi” addresses) appears repeatedly across multiple dates and amounts, including ADEL (2026-06-11 $2M), Cureverse (2026-05-21 $990K), Spark Biopharma (2026-05-11 $21M), Shaperon (2026-04-09 $6M), and ROKIT Healthcare (2026-04-13 undisclosed). Outside Seoul, Daejeon appears for LegoChem Biosciences ($214M on 2026-06-26) and Jeju for Jeju Salt (2026-04-22 undisclosed).
How does stage disclosure look across the rows shown?
“Series Unknown” dominates this slice at 9 of 11 rows. The only explicitly labeled stage is Seed for Jeju Salt on 2026-04-22, and the remaining disclosed amounts (e.g., Cureverse $990K on 2026-05-21 and SN BioScience $9M on 2026-04-07) still sit under “Series Unknown.”
Are there notable outliers worth focusing on besides the top disclosed round?
Yes on both ends. Cureverse’s $990K (2026-05-21) is the smallest disclosed amount in the rows, far below other disclosed mid-single/low-double-digit rounds like Shaperon’s $6M (2026-04-09) and SN BioScience’s $9M (2026-04-07), while two undisclosed entries (Jeju Salt on 2026-04-22 and ROKIT Healthcare on 2026-04-13) limit comparisons around that period.
Which entries fall at the most recent edge of the date range shown?
The most recent date in the 11-row list is 2026-06-26 with LegoChem Biosciences at $214M. The immediately adjacent day (2026-06-25) is April Bio at $124M, making the latest two rounds both large and back-to-back in late June.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.